Grey Street Capital’s Bristol-Myers Squibb BMY Stock Holding History

Grey Street Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$909K	Buy	16,771 +11,745	+234%	+$598K	0.12%	191
2023 Q4	$258K	Buy	5,026 +70	+1%	+$3.67K	0.12%	113
2023 Q3	$288K	Buy	4,956 +38	+0.8%	+$2.33K	0.16%	101
2023 Q2	$315K	Buy	+4,918	New	+$330K	0.17%	94

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Grey Street Capital's BMY Position: Q1 2024 in Review

Grey Street Capital increased its Bristol-Myers Squibb (BMY) stake by 234% in Q1 2024, buying an estimated $598K and bringing the position to 16,771 shares worth $909K. The position accounts for 0.12% of the portfolio, ranked #191.

Grey Street Capital first reported a position in BMY in Q2 2023 and has held it in 4 quarters since. 2,334 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Grey Street Capital held 16,771 shares of Bristol-Myers Squibb worth $909K as of Q1 2024.
Grey Street Capital bought 11,745 Bristol-Myers Squibb shares in Q1 2024, an estimated $598K.
Bristol-Myers Squibb made up 0.12% of Grey Street Capital's portfolio in Q1 2024, its #191 holding.
Grey Street Capital first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 4 quarters since.
2,334 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Grey Street Capital's 13F filing for Q1 2024, filed 9 Aug 2024.